Last 12 months
Inside the activity.
5 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2018 Filed Oct 2, 2018 12:49 UTC |
Riggsbee Richard BryanChief Financial Officer
|
Disposition to issuerCommon Stock | 5,289 | $46.00 | $243,294.00 |
DisclosureSEC source: 0001621899-18-000008 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,946 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 12:45 UTC |
Capone Mark ChristopherPresident & C.E.O.
|
Disposition to issuerCommon Stock | 8,727 | $46.00 | $401,442.00 |
DisclosureSEC source: 0001352413-18-000012 · edgardoc.xml · nonDerivative · entry 2 Capone Mark Christopher · CIK 0001352413 · President & C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,833 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 12:45 UTC |
Capone Mark ChristopherPresident & C.E.O.
|
Disposition to issuerCommon Stock | 18,295 | $46.00 | $841,570.00 |
DisclosureSEC source: 0001352413-18-000012 · edgardoc.xml · nonDerivative · entry 1 Capone Mark Christopher · CIK 0001352413 · President & C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 449,560 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:55 UTC |
Capone Mark ChristopherPresident & C.E.O.
|
Disposition to issuerCommon Stock | 18,295 | $46.65 | $853,461.75 |
DisclosureSEC source: 0001352413-18-000010 · edgardoc.xml · nonDerivative · entry 1 Capone Mark Christopher · CIK 0001352413 · President & C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 467,855 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:43 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Disposition to issuerCommon Stock | 5,544 | $46.65 | $258,627.60 |
DisclosureSEC source: 0001219036-18-000010 · edgardoc.xml · nonDerivative · entry 1 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,750 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:50 UTC |
Ford AlexanderPresident, MGL
|
Disposition to issuerCommon Stock | 6,653 | $46.65 | $310,362.45 |
DisclosureSEC source: 0001644335-18-000006 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,007 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:40 UTC |
MARSH RICHARD ME.V.P., General Counsel
|
Disposition to issuerCommon Stock | 5,544 | $46.65 | $258,627.60 |
DisclosureSEC source: 0001206386-18-000018 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,716 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:36 UTC |
Riggsbee Richard BryanChief Financial Officer
|
Disposition to issuerCommon Stock | 6,653 | $46.65 | $310,362.45 |
DisclosureSEC source: 0001621899-18-000006 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,235 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:33 UTC |
Verratti MarkPresident Assurex Health Inc.
|
Disposition to issuerCommon Stock | 2,897 | $46.65 | $135,145.05 |
DisclosureSEC source: 0001517026-18-000004 · edgardoc.xml · nonDerivative · entry 1 Verratti Mark · CIK 0001517026 · President Assurex Health Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,303 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:23 UTC |
Sanders Walter LloydPresident Myriad Oncology
|
Disposition to issuerCommon Stock | 1,664 | $46.65 | $77,625.60 |
DisclosureSEC source: 0001349943-18-000010 · edgardoc.xml · nonDerivative · entry 1 Sanders Walter Lloyd · CIK 0001349943 · President Myriad Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,453 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:30 UTC |
King Gary A.Exec. VP International Ops
|
Disposition to issuerCommon Stock | 3,327 | $46.65 | $155,204.55 |
DisclosureSEC source: 0001495800-18-000010 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,126 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:27 UTC |
Tobin BernardPresident Crescendo BioScience
|
Disposition to issuerCommon Stock | 4,958 | $46.65 | $231,290.70 |
DisclosureSEC source: 0001628656-18-000006 · edgardoc.xml · nonDerivative · entry 1 Tobin Bernard · CIK 0001628656 · President Crescendo BioScience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,593 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 25, 2018 Filed Sep 26, 2018 18:20 UTC |
McDade Ralph LPresident Myriad RBM, Inc.
|
Disposition to issuerCommon Stock | 2,952 | $46.65 | $137,710.80 |
DisclosureSEC source: 0001594674-18-000006 · edgardoc.xml · nonDerivative · entry 1 McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,578 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:27 UTC |
McDade Ralph LPresident Myriad RBM, Inc.
|
GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001594674-18-000004 · edgardoc.xml · nonDerivative · entry 1 McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,530 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:25 UTC |
Tobin BernardPresident Crescendo BioScience
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628656-18-000004 · edgardoc.xml · nonDerivative · entry 1 Tobin Bernard · CIK 0001628656 · President Crescendo BioScience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,551 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:22 UTC |
King Gary A.Exec. VP International Ops
|
GrantCommon Stock | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001495800-18-000008 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,453 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:19 UTC |
Verratti MarkPresident Assurex Health Inc.
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001517026-18-000002 · edgardoc.xml · nonDerivative · entry 1 Verratti Mark · CIK 0001517026 · President Assurex Health Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,200 F1 · kind: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:14 UTC |
Ford AlexanderPresident, MGL
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001644335-18-000004 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,660 F1 · kind: Consists of performance stock units granted pursuant to the Companys 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 17, 2017, subject to accomplishment of pre-determined financial performance requirements. On September 19, 2018, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:11 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001219036-18-000008 · edgardoc.xml · nonDerivative · entry 1 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,294 F1 · kind: Consists of performance stock units granted pursuant to the Companys 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 17, 2017, subject to accomplishment of pre-determined financial performance requirements. On September 19, 2018, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:08 UTC |
MARSH RICHARD ME.V.P., General Counsel
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001206386-18-000016 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,260 F1 · kind: Consists of performance stock units granted pursuant to the Companys 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 17, 2017, subject to accomplishment of pre-determined financial performance requirements. On September 19, 2018, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:06 UTC |
Riggsbee Richard BryanChief Financial Officer
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001621899-18-000004 · edgardoc.xml · nonDerivative · entry 1 Riggsbee Richard Bryan · CIK 0001621899 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,888 F1 · kind: Consists of performance stock units granted pursuant to the Companys 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 17, 2017, subject to accomplishment of pre-determined financial performance requirements. On September 19, 2018, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021. Read SEC document |
| September 19, 2018 Filed Sep 21, 2018 16:02 UTC |
Capone Mark ChristopherPresident & C.E.O.
|
GrantCommon Stock | 165,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001352413-18-000008 · edgardoc.xml · nonDerivative · entry 1 Capone Mark Christopher · CIK 0001352413 · President & C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,150 F1 · kind: Consists of performance stock units granted pursuant to the Companys 2010 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 17, 2017, subject to accomplishment of pre-determined financial performance requirements. On September 19, 2018, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Company?s common stock,and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:22 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Disposition to issuerCommon Stock | 6,515 | $46.35 | $301,970.25 |
DisclosureSEC source: 0001219036-18-000006 · edgardoc.xml · nonDerivative · entry 1 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,294 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:15 UTC |
Capone Mark ChristopherPresident & C.E.O.
|
Disposition to issuerCommon Stock | 11,025 | $46.35 | $511,008.75 |
DisclosureSEC source: 0001352413-18-000006 · edgardoc.xml · nonDerivative · entry 1 Capone Mark Christopher · CIK 0001352413 · President & C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,150 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 20:13 UTC |
MARSH RICHARD ME.V.P., General Counsel
|
Disposition to issuerCommon Stock | 6,314 | $46.35 | $292,653.90 |
DisclosureSEC source: 0001206386-18-000014 · edgardoc.xml · nonDerivative · entry 1 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,260 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 18:26 UTC |
Sanders Walter LloydPresident Myriad Oncology
|
Disposition to issuerCommon Stock | 844 | $46.35 | $39,119.40 |
DisclosureSEC source: 0001349943-18-000008 · edgardoc.xml · nonDerivative · entry 1 Sanders Walter Lloyd · CIK 0001349943 · President Myriad Oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,117 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 18:35 UTC |
King Gary A.Exec. VP International Ops
|
Disposition to issuerCommon Stock | 5,101 | $46.35 | $236,431.35 |
DisclosureSEC source: 0001495800-18-000006 · edgardoc.xml · nonDerivative · entry 1 King Gary A. · CIK 0001495800 · Exec. VP International Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,453 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 18:21 UTC |
Ford AlexanderPresident, MGL
|
Disposition to issuerCommon Stock | 1,830 | $46.35 | $84,820.50 |
DisclosureSEC source: 0001644335-18-000002 · edgardoc.xml · nonDerivative · entry 1 Ford Alexander · CIK 0001644335 · President, MGL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,660 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| September 17, 2018 Filed Sep 18, 2018 18:18 UTC |
McDade Ralph LPresident Myriad RBM, Inc.
|
Disposition to issuerCommon Stock | 3,148 | $46.35 | $145,909.80 |
DisclosureSEC source: 0001594674-18-000002 · edgardoc.xml · nonDerivative · entry 1 McDade Ralph L · CIK 0001594674 · President Myriad RBM, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,530 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:25 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 46,139 | $0.00 Strike: $30.34 | $0.00 |
DisclosureSEC source: 0001219036-18-000004 · edgardoc.xml · derivative · entry 6 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,139 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:25 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 3,861 | $0.00 Strike: $30.34 | $0.00 |
DisclosureSEC source: 0001219036-18-000004 · edgardoc.xml · derivative · entry 5 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,861 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:25 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
SaleCommon Stock | 3,861 | $43.34 | $167,338.83 |
DisclosureSEC source: 0001219036-18-000004 · edgardoc.xml · nonDerivative · entry 4 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,809 Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:25 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Exercise / conversionCommon Stock | 3,861 | $30.34 | $117,142.74 |
DisclosureSEC source: 0001219036-18-000004 · edgardoc.xml · nonDerivative · entry 3 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:25 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
SaleCommon Stock | 46,139 | $43.34 | $1,999,701.17 |
DisclosureSEC source: 0001219036-18-000004 · edgardoc.xml · nonDerivative · entry 2 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,809 Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:25 UTC |
LANCHBURY JERRY SChief Scientific Officer
|
Exercise / conversionCommon Stock | 46,139 | $30.34 | $1,399,857.26 |
DisclosureSEC source: 0001219036-18-000004 · edgardoc.xml · nonDerivative · entry 1 LANCHBURY JERRY S · CIK 0001219036 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:23 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $24.39 | $0.00 |
DisclosureSEC source: 0001226488-18-000002 · edgardoc.xml · derivative · entry 10 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2018-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:23 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $24.39 | $0.00 |
DisclosureSEC source: 0001226488-18-000002 · edgardoc.xml · derivative · entry 9 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2018-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:23 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $24.39 | $0.00 |
DisclosureSEC source: 0001226488-18-000002 · edgardoc.xml · derivative · entry 8 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires 2018-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:23 UTC |
HENDERSON JOHN TDirector
|
SaleCommon Stock | 10,000 | $40.17 | $401,700.00 |
DisclosureSEC source: 0001226488-18-000002 · edgardoc.xml · nonDerivative · entry 6 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,743 Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:23 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionCommon Stock | 10,000 | $24.39 | $243,900.00 |
DisclosureSEC source: 0001226488-18-000002 · edgardoc.xml · nonDerivative · entry 5 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:23 UTC |
HENDERSON JOHN TDirector
|
SaleCommon Stock | 10,000 | $42.01 | $420,085.00 |
DisclosureSEC source: 0001226488-18-000002 · edgardoc.xml · nonDerivative · entry 4 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,743 Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:23 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionCommon Stock | 10,000 | $24.39 | $243,900.00 |
DisclosureSEC source: 0001226488-18-000002 · edgardoc.xml · nonDerivative · entry 3 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:23 UTC |
HENDERSON JOHN TDirector
|
SaleCommon Stock | 10,000 | $44.00 | $440,000.00 |
DisclosureSEC source: 0001226488-18-000002 · edgardoc.xml · nonDerivative · entry 2 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,743 Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:23 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionCommon Stock | 10,000 | $24.39 | $243,900.00 |
DisclosureSEC source: 0001226488-18-000002 · edgardoc.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC |
MARSH RICHARD ME.V.P., General Counsel
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $23.11 | $0.00 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · derivative · entry 7 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2020-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC |
MARSH RICHARD ME.V.P., General Counsel
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 30,672 | $0.00 Strike: $23.11 | $0.00 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · derivative · entry 6 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 30,672 shares Expires 2020-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC |
MARSH RICHARD ME.V.P., General Counsel
|
GiftCommon Stock | 7,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · nonDerivative · entry 5 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,574 Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC |
MARSH RICHARD ME.V.P., General Counsel
|
SaleCommon Stock | 40,000 | $42.02 | $1,680,652.00 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · nonDerivative · entry 4 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,197 Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC |
MARSH RICHARD ME.V.P., General Counsel
|
Exercise / conversionCommon Stock | 40,000 | $23.11 | $924,400.00 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · nonDerivative · entry 3 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 11, 2018 Filed Jul 13, 2018 20:19 UTC |
MARSH RICHARD ME.V.P., General Counsel
|
SaleCommon Stock | 30,672 | $44.00 | $1,349,568.00 |
DisclosureSEC source: 0001206386-18-000012 · edgardoc.xml · nonDerivative · entry 2 MARSH RICHARD M · CIK 0001206386 · E.V.P., General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,197 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.